What does Pharmakaisercentre do?

Pharmakaisercentre is a pharmacy in Sprimont. Private Limited, started on 1 December 2014, 1 establishment.

What is the address of Pharmakaisercentre?

The registered office of Pharmakaisercentre is located at Rue du Centre 21, 4140 Sprimont.

Is Pharmakaisercentre still active?

Yes. According to the CBE (30 October 2026) Pharmakaisercentre is active, legal situation “Normale toestand”, started on 1 December 2014.

Is Pharmakaisercentre registered on Peppol?

Yes, Pharmakaisercentre is registered on the Peppol network with ID 0208:0505823623.

What is the enterprise number of Pharmakaisercentre?

The enterprise number of Pharmakaisercentre is BE0505823623.

When was Pharmakaisercentre founded?

Pharmakaisercentre was founded on 1 December 2014.

Who are the directors of Pharmakaisercentre?

According to the 2025 annual accounts, the directors of Pharmakaisercentre are: Audrey Kaiser.

Is Pharmakaisercentre a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 December 2014; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Pharmakaisercentre make in 2025?

Pharmakaisercentre posted a profit after taxes of € 50,800 in financial year 2025.

What is the revenue of Pharmakaisercentre?

As a small company, Pharmakaisercentre is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 288,915.

How much does an employee at Pharmakaisercentre earn?

The average wage cost per full-time employee at Pharmakaisercentre was € 78,300 in 2025: staff costs of € 133,130 for 1.7 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Pharmakaisercentre have?

According to the 2025 annual accounts, Pharmakaisercentre has 1.7 full-time equivalents (FTE).

Pharmakaisercentre (Private Limited) - Sprimont

Dossier Pharmakaisercentre, printed on 30 October 2026 from databakkes.be/en/0505823623/pharmakaisercentre. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 28 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Pharmakaisercentre from Sprimont, company number BE0505823623, closed financial year 2025 with a result of € 50,800 after tax. For that financial year Pharmakaisercentre recorded a gross margin of € 288,915 and equity of € 216,481. Compared with financial year 2024, the result moved from € 37,304 to € 50,800. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 30, 2026.

What it is worth Growing

€ 216,481

▲ 31% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 50,800

▲ 36% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 69,298

▲ 53% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 204,081.

People and assets in 2025

Full-time equivalents

1.7

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 133,130

▲ 1% vs 2024

€ 78,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 616,649

▼ 13% vs 2024

€ 74,211 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 58,996

▼ 42% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 25,227

▲ 48% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 205,549 Gross margin 2022: € 205,549 First fiscal year in the series	€ 209,206 Gross margin 2023: € 209,206 ▲ 2% vs 2022 (€ 205,549) Favourable step	€ 286,472 Gross margin 2024: € 286,472 ▲ 37% vs 2023 (€ 209,206) Favourable step	€ 288,915 Gross margin 2025: € 288,915 ▲ 1% vs 2024 (€ 286,472) Favourable step	▲ 1%
Profit after taxes	€ -26,813 Profit after taxes 2022: € -26,813 First fiscal year in the series	€ -67,536 Profit after taxes 2023: € -67,536 ▼ € 40,723 vs 2022 (€ -26,813) Unfavourable step	€ 37,304 Profit after taxes 2024: € 37,304 ▲ € 104,840 vs 2023 (€ -67,536) Favourable step	€ 50,800 Profit after taxes 2025: € 50,800 ▲ 36% vs 2024 (€ 37,304) Favourable step	▲ 36%
Equity	€ 195,913 Equity 2022: € 195,913 First fiscal year in the series	€ 128,377 Equity 2023: € 128,377 ▼ 34% vs 2022 (€ 195,913) Unfavourable step	€ 165,681 Equity 2024: € 165,681 ▲ 29% vs 2023 (€ 128,377) Favourable step	€ 216,481 Equity 2025: € 216,481 ▲ 31% vs 2024 (€ 165,681) Favourable step	▲ 31%
Total debts	€ 1,448,310 Total debts 2022: € 1,448,310 First fiscal year in the series	€ 1,351,896 Total debts 2023: € 1,351,896 ▼ 7% vs 2022 (€ 1,448,310) Favourable step	€ 1,220,661 Total debts 2024: € 1,220,661 ▼ 10% vs 2023 (€ 1,351,896) Favourable step	€ 1,067,055 Total debts 2025: € 1,067,055 ▼ 13% vs 2024 (€ 1,220,661) Favourable step	▼ 13%
Cash	€ 135,265 Cash 2022: € 135,265 First fiscal year in the series	€ 47,957 Cash 2023: € 47,957 ▼ 65% vs 2022 (€ 135,265) Unfavourable step	€ 45,385 Cash 2024: € 45,385 ▼ 5% vs 2023 (€ 47,957) Unfavourable step	€ 69,298 Cash 2025: € 69,298 ▲ 53% vs 2024 (€ 45,385) Favourable step	▲ 53%
Land & buildings	€ 1,182,944 Land & buildings 2022: € 1,182,944 First fiscal year in the series	€ 1,112,738 Land & buildings 2023: € 1,112,738 ▼ 6% vs 2022 (€ 1,182,944) Unchanged	€ 1,042,531 Land & buildings 2024: € 1,042,531 ▼ 6% vs 2023 (€ 1,112,738) Unchanged	€ 974,858 Land & buildings 2025: € 974,858 ▼ 6% vs 2024 (€ 1,042,531) Unchanged	▼ 6%
Retained profit	€ 183,513 Retained profit 2022: € 183,513 First fiscal year in the series	€ 115,977 Retained profit 2023: € 115,977 ▼ 37% vs 2022 (€ 183,513) Unfavourable step	€ 153,281 Retained profit 2024: € 153,281 ▲ 32% vs 2023 (€ 115,977) Favourable step	€ 204,081 Retained profit 2025: € 204,081 ▲ 33% vs 2024 (€ 153,281) Favourable step	▲ 33%
Bank debt	€ 900,610 Bank debt 2022: € 900,610 First fiscal year in the series	€ 814,983 Bank debt 2023: € 814,983 ▼ 10% vs 2022 (€ 900,610) Favourable step	€ 705,532 Bank debt 2024: € 705,532 ▼ 13% vs 2023 (€ 814,983) Favourable step	€ 616,649 Bank debt 2025: € 616,649 ▼ 13% vs 2024 (€ 705,532) Favourable step	▼ 13%
Balance sheet total	€ 1,644,223 Balance sheet total 2022: € 1,644,223 First fiscal year in the series	€ 1,480,272 Balance sheet total 2023: € 1,480,272 ▼ 10% vs 2022 (€ 1,644,223) Unchanged	€ 1,386,342 Balance sheet total 2024: € 1,386,342 ▼ 6% vs 2023 (€ 1,480,272) Unchanged	€ 1,283,536 Balance sheet total 2025: € 1,283,536 ▼ 7% vs 2024 (€ 1,386,342) Unchanged	▼ 7%
Employees (FTE)	2.6 Employees (FTE) 2022: 2.6 First fiscal year in the series	-	1.7 Employees (FTE) 2024: 1.7 First fiscal year in the series	1.7 Employees (FTE) 2025: 1.7 Unchanged (1.7) Unchanged

Key figures of Pharmakaisercentre, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Pharmakaisercentre?

What happened at Pharmakaisercentre in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 30, 2026 New annual accounts for financial year 2025: profit of € 50,800 (▲ 36% vs 2024). filed late Source: NBB ↗
Dec 1, 2014 New establishment in Sprimont. KBO
2014 Audrey Kaiser became a director. NBB
Dec 1, 2014 Start of the company according to the CBE. KBO

In short

From € 26,813 loss in 2022 to € 50,800 profit in 2025.

Paid € 2,418 in corporate taxes since 2022.

Best year ever: 2025, with € 50,800 profit.

On average € 169,900 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Audrey Kaiser

Pharmakaisercentre

AUDREY KAISER MANAGEMENT

PHARMAKAISER GRIVEGNEE

Behind Pharmakaisercentre is Audrey Kaiser. Audrey Kaiser is also behind AUDREY KAISER MANAGEMENT and PHARMAKAISER GRIVEGNEE.

Directors

According to the 2025 annual accounts

Audrey Kaiser

Director

Also active at: AUDREY KAISER MANAGEMENT, PHARMAKAISER GRIVEGNEE

since 2014

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Centre 21

4140 Sprimont

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

AUDREY KAISER MANAGEMENT same network

€ 60,051 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0505.823.623
VAT number: BE 0505.823.623
Registered office: Rue du Centre 21, 4140 Sprimont
Names & denominations: Pharmakaisercentre
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 1 December 2014
Peppol: Active · Active since 27 Nov 2025
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗